Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study
Makaleler > Tam Makale · 2014
Yazarlar: Frederic CASTINETTI, Xiao-Ping QI, Martin K. WALZ, Ana Luiza MAIA, Gabriela SANSO, Mariola PECZKOWSKA, Kornelia HASSE-LAZAR, Thera P. LINKS, Sarka DVORAKOVA, Rodrigo A. Toledo, Caterina MIAN, Maria Joao Bugalho, Nelson WOHLLK, Oleg KOLLYUKH, Letizia CANU, Paola LOLI, Simona R. BERGMANN, Josefina Biarnes COSTA, Özer MAKAY, Attila PATOCS, Marija PFEIFER, Nalini S. SHAH, Thomas CUNY, Michael BRAUCKHOFF, Birke BAUSCH, Ernst VON DOBSCHUETZ, Claudio LETIZIA, Marcin BARCZYNSKI, Maria K. ALEVIZAKI, Malgorzata CZETWERTYNSKA, M. Umit Ugurlu, Gerlof Valk, John T. M. PLUKKER, Paola SARTORATO, Debora R. SIQUEIRA, Marta BARONTINI, Malgorzata SZPERL, Barbara JARZAB, Hans H. G. VERBEEK, Tomas ZELINKA, Petr VLCEK, Sergio P. A. Toledo, Flavia L. Coutinho, Massimo MANNELLI, Monica RECASENS, Lea DEMARQUET, Luigi PETRAMALA, Svetlana YAREMCHUK, Dmitry ZABOLOTNYI, Francesca SCHIAVI, Giuseppe OPOCHER, Karoly Racz, Andrzej JANUSZEWICZ, Georges WERYHA, Jean-Francois HENRY, Thierry BRUE, Bernard CONTE-DEVOLX, Charis ENG, Hartmut P. H. NEUMANN
The Lancet Oncology, SCI Expanded İndekslerine Giren Dergi, Uluslararası, Wos, 2014, cilt 15, ss 648-655
DOI: 10.1016/s1470-2045(14)70154-8
Özet
Background The prevention of medullary thyroid cancer in patients with multiple endocrine neoplasia type 2 syndrome has demonstrated the ability of molecular diagnosis and prophylactic surgery to improve patient outcomes. However, the other major neoplasia associated with multiple endocrine neoplasia type 2, phaeochromocytoma, is not as well characterised in terms of occurrence and treatment outcomes. In this study, we aimed to systematically characterise the outcomes of management of phaeochromocytoma associated with multiple endocrine neoplasia type 2.